There are 2789 resources available
Current landscape: Did we learn how to select first-line strategy?
Presenter: Edward Garon
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Mechanisms of resistance and novel strategies
Presenter: Céline Mascaux
Session: Refining the use of immune-checkpoint inhibition
Resources:
Abstract
Slides
Webcast
Do we have any idea how to use these drugs in oncogene addicted patients yet?
Presenter: Julien Mazieres
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Introduction
Presenter: Sanjay Popat
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Broadening the horizons: EGFR, ALK, ROS-1, BRAF
Presenter: Christine Lovly
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
Introduction
Presenter: Pieter Sonneveld
Session: News and strategies in multiple myeloma
Resources:
Slides
Webcast
New insights in the genetics and biology of multiple myeloma
Presenter: Norma Gutierrez
Session: News and strategies in multiple myeloma
Resources:
Slides
Webcast
New treatment strategies: CAR T cell and more
Presenter: Francesca Gay
Session: News and strategies in multiple myeloma
Resources:
Slides
Webcast
Treatment strategies and sequencing
Presenter: Pieter Sonneveld
Session: News and strategies in multiple myeloma
Resources:
Slides
Webcast
Introduction
Presenter: Andrew Neil Tippings Davies
Session: Complementary therapies and cannabinoids: Evidence is gathering
Resources:
Slides
Webcast